8-K
filed June 15, 2023, 7:59 PM ET
ticker TEVA
CIK 0000818686
other material
confidence high
sentiment negative
materiality 0.15
Teva shareholders reject advisory vote on executive compensation at 2023 annual meeting
TEVA PHARMACEUTICAL INDUSTRIES LTD
- Elected directors Sol J. Barer and Janet S. Vergis with ~490M and ~498M votes for, respectively.
- Say-on-pay proposal failed: 319.2M for, 324.5M against, showing majority disapproval.
- Auditor Kesselman & Kesselman (PwC) ratified with 712.7M votes for, 35.8M against.
- Approximately 103.9M broker non-votes on director and say-on-pay items.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
TEVA PHARMACEUTICAL INDUSTRIES LTD shareholders approved Ratification of appointment of Kesselman & Kesselman (PwC) as independent auditor at the 2023-06-15 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-15
Exact text from the filing
The shareholders approved the appointment of Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2024 annual meeting of shareholders, as follows: For Against Abstain Brokers non-vote 712,745,286 35,777,701 1,019,646 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
TEVA PHARMACEUTICAL INDUSTRIES LTD shareholders rejected Non-binding advisory vote on executive compensation at the 2023-06-15 meeting.
- Proposal
- say on pay
- Outcome
- failed
- Meeting
- 2023-06-15
Exact text from the filing
The shareholders did not approve, on a non-binding advisory basis, the compensation for Teva's named executive officers listed in the proxy statement for the Annual Meeting, as follows: For Against Abstain Brokers non-vote 319,197,368 324,474,010 5,417,079 103,855,164
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
TEVA PHARMACEUTICAL INDUSTRIES LTD shareholders approved Election of Directors at the 2023-06-15 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-15
Exact text from the filing
The shareholders elected to appoint the following persons to the Board, to serve until Teva's 2026 annual meeting of shareholders, as follows: Directors For Against Abstain Brokers non-vote Dr. Sol J. Barer 490,224,315 153,968,878 4,893,082 103,855,164 Janet S. Vergis 498,422,096 145,733,938 4,930,241 103,855,164
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.